Cited by 254Advanced Glycation End Products researchAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

Sasaki, Nobuyuki, Toki, Sadamu, Chowei, Hiroshi, Saito, Toshikazu, Nakano, Norihito, Hayashi, Yorihide, Takeuchi, Masayoshi, Makita, Zenji·2001·Brain Research

DOI 10.1016/s0006-8993(00)03075-4

Open this paper in CoChat — free account

Abstract

Advanced glycation end products (AGE) and the receptor for AGE (RAGE) have been implicated in the chronic complications of diabetes mellitus (DM), and have been reported to play an important role in the pathogenesis of Alzheimer's disease (AD). In this study, we established a polyclonal anti-RAGE antibody, and examined the immunohistochemical localization of amyloid beta protein (Abeta), AGE, and RAGE in neurons and astrocytes from patients with AD and DM. Our anti-RAGE antibody recognized full-length RAGE (50 kd) and N-terminal RAGE (35 kd) in human brain tissue. Abeta-, AGE-, and RAGE-positive granules were identified in the perikaryon of hippocampal neurons (especially from CA3 and CA4) in all subjects. The distribution and staining pattern of these immunopositive granules showed good concordance with each antibody. In AD, most astrocytes contained both AGE-and RAGE-positive granules and their distribution was almost the same. Abeta-positive granules were less common, but Abeta-, AGE-, and RAGE-positive granules were colocalized in one part of a single astrocyte. In DM patients and control cases, AGE-and RAGE-positive astrocytes were very rare. These finding support the hypothesis that glycated Abeta is taken up via RAGE and is degraded through the lysosomal pathway in astrocytes. In addition to the presence of AGE, the process of AGE degradation and receptor-mediated reactions may contribute to neuronal dysfunction and promote the progression of AD.

Integrity signals

Registry

Crossref · 10.1016/s0006-8993(00)03075-4

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,545
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
Brownlee, M., Vlassara, H., & Cerami, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,010
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 773
The Pathogenesis of Senile Plaques
DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753
New Aspects of the Maillard Reaction in Foods and in the Human Body
Ledl, F., & Schleicher, E. D. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199005653 · Cited by 738
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 715

Show all 29 references

Sorted by citations

Items 101–200 of 254

From obesity to Alzheimer's disease through insulin resistance
Terzo, S., Amato, A., & Mulè, F. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108026 · Cited by 63
D-Ribose Induces Cellular Protein Glycation and Impairs Mouse Spatial Cognition
Han, C., Lü, Y., Yan, W., Liu, Y. M., & He, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024623 · Cited by 62
Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo
Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.005 · Cited by 62
Self-citation
Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota
Liu, J., Ye, T., Zhang, Y., Zhang, R., Kong, Y., Zhang, Y., & Sun, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05038 · Cited by 62
Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome
Kimpe, L. D., van Haastert, E. S., Kaminari, A., Zwart, R., Rutjes, H., Hoozemans, J. J. M., & Scheper, W. (2012) · AGE · doi:10.1007/s11357-012-9403-0 · Cited by 61
RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair
Rong, L., Gooch, C. L., Szabolcs, M., Herold, K. C., Lalla, E., Hays, A. P., Yan, S. F., Yan, S. S. D., & Schmidt, A. M. (2005) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2005-00322 · Cited by 58
Expression and cell distribution of receptor for advanced glycation end-products in the rat cortex following experimental subarachnoid hemorrhage
Li, H., Wu, W. H., Sun, Q., Liu, M., Li, W., Zhang, X., Zhou, M., & Hang, C. (2013) · Brain Research · doi:10.1016/j.brainres.2013.11.023 · Cited by 58
Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomics
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300066 · Cited by 59
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
Antidiabetic Drugs in Alzheimer’s Disease: Mechanisms of Action and Future Perspectives
Femminella, G. D., Bencivenga, L., Petraglia, L., Visaggi, L., Gioia, L., Grieco, F. V., de Lucia, C., Komici, K., Corbi, G., Edison, P., et al. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7420796 · Cited by 57
Receptor for Advanced Glycation end Products: Its Role in Alzheimer‘s Disease and other Neurological Diseases
Lue, L., Walker, D. G., Jacobson, S. A., & Sabbagh, M. N. (2009) · Future Neurology · doi:10.2217/14796708.4.2.167 · Cited by 54
Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus
Ma, L., & Nicholson, L. F. B. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.052 · Cited by 54
A Novel Mechanism for Endogenous Formaldehyde Elevation in SAMP8 Mouse
Qiang, M., Xiao, R., Su, T., Wu, B., Tong, Z., Liu, Y., & He, R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131595 · Cited by 53
Streptozotocin-induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/RAGE/NF-κB pathway
Wang, X., Yu, S., Hu, J.-P., Wang, C., Wang, Y., Liu, H.-X., & Liu, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.866110 · Cited by 55
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 54
Ribosylation triggering A lzheimer's disease‐like T au hyperphosphorylation via activation of C a MKII
Yan, W., Han, C., Wang, Y., Wu, B., Su, T., Liu, Y., & He, R. (2015) · Aging Cell · doi:10.1111/acel.12355 · Cited by 53
Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by β-amyloid peptide acting through receptor for advanced glycation end products (RAGE)
Onyango, I. G., Tuttle, J. B., & Bennett, J. P. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.012 · Cited by 50
An update on treatment and prevention strategies for Alzheimer’s disease
Neugroschl, J. A., & Sano, M. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0054-1 · Cited by 50
D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation
Han, C., Lü, Y., Wei, Y., Wu, B., Liu, Y., & He, R. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.89 · Cited by 50
Glia as a putative target for antidepressant treatments
Manev, H., Uz, T., & Manev, R. M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00044-7 · Cited by 50
Oxidative stress in Alzheimer's disease hippocampus: A topographical study
Cruz-Sánchez, F. F., Gironès, X., Aznar, A. O., Alameda, F., & Lafuente, J. V. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.029 · Cited by 49
Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia
Southern, L., Williams, J. H., & Esiri, M. M. (2007) · BMC Neurology · doi:10.1186/1471-2377-7-35 · Cited by 47
Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway
Chen, C., Li, X.-H., Tu, Y., Sun, H.-T., Liang, H., Cheng, S., & Zhang, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.056 · Cited by 46
The Relationship Between Inflammation and Impaired Wound Healing in a Diabetic Rat Burn Model
Tian, M., Qing, C., Niu, Y., Dong, J., Cao, X., Song, F., Ji, X., & Lu, S. (2014) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000171 · Cited by 46
Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes‐Mediated Alzheimer’s Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin
Khan, M. S., Ikram, M. A., Park, T. J., & Kim, M. O. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4051207 · Cited by 46
Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis
Davies, C. A., Herrick, A. L., Cordingley, L., Freemont, A. J., & Jeziorska, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep151 · Cited by 47
Crucial players in Alzheimer’s disease and diabetes mellitus: Friends or foes?
Kubis-Kubiak, A., Rorbach-Dolata, A., & Piwowar, A. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.008 · Cited by 47
Pattern recognition receptors in chronic pain: Mechanisms and therapeutic implications
Kato, J., Agalave, N. M., & Svensson, C. I. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.039 · Cited by 44
Significant Modifications of the Salivary Proteome Potentially Associated with Complications of Down Syndrome Revealed by Top-down Proteomics
Cabras, T., Pisano, E., Montaldo, C., Giuca, M. R., Iavarone, F., Zampino, G., Castagnola, M., & Messana, I. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026708 · Cited by 42
Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer’s disease
Takeuchi, M., Sato, T., Takino, J.-I., Kobayashi, Y., Furuno, S., Kikuchi, S., & Yamagishi, S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.017 · Cited by 43
Self-citation
Glycation, glycolysis, and neurodegenerative diseases: Is there any connection?
Muronetz, V. I., Melnikova, A. K., Seferbekova, Z., Barinova, K. V., & Schmalhausen, E. V. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917080028 · Cited by 41
Icariin ameliorate Alzheimer’s disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis
Chuang, Y. C., Van, I., Zhao, Y., & Xu, Y. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102014 · Cited by 41
The RAGE receptor and its ligands are highly expressed in astrocytes in a grade‐dependant manner in the striatum and subependymal layer in Huntington's disease
Kim, J., Waldvogel, H. J., Faull, R. L. M., Curtis, M. A., & Nicholson, L. F. B. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13178 · Cited by 39
Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease
Anzilotti, S., Giampà, C., Laurenti, D., Perrone, L., Bernardi, G., Melone, M. A. B., & Fusco, F. R. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.01.009 · Cited by 39
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions
Koerich, S., Parreira, G. M., de Almeida, D. L., Vieira, R. P., & de Oliveira, A. C. P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922153903 · Cited by 40
Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?
Yan, L., Xiao, M., Chen, R., & Cai, Z. (2013) · PubMed · Cited by 39
Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease
Wang, M. Y., Ross-Cisneros, F. N., Aggarwal, D., Liang, C.-Y., & Sadun, A. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0513-4 · Cited by 38
The Role of Vitamin D in Alzheimer’s Disease
Lương, K. V. Q., & Nguyễn, L. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512473196 · Cited by 37
Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts
Cary, B. P., Brooks, A. F., Fawaz, M. V., Drake, L. R., Desmond, T. J., Sherman, P. S., Quesada, C., & Scott, P. J. H. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00319 · Cited by 36
Protective Effects of Grape Seed Proanthocyanidin Extracts on Cerebral Cortex of Streptozotocin-Induced Diabetic Rats through Modulating AGEs/RAGE/NF-κB Pathway
Lü, M., Xu, L., Li, B., Zhang, W., Zhang, C., Hong, F. E. N. G., Cui, X., & Gao, H. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.87 · Cited by 36
Neurotoxicity of Acetaldehyde-Derived Advanced Glycation End Products for Cultured Cortical Neurons
Takeuchi, M., Watai, T., Sasaki, N., Choei, H., Iwaki, M., Ashizawa, T., Inagaki, Y., Yamagishi, S.-I., Kikuchi, S., Riederer, P., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.486 · Cited by 36
Self-citation
Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and Neurodegeneration
Loera‐Valencia, R., Ismail, M.-A.-M., Goikolea, J., Lodeiro, M., Mateos, L., Björkhem, I., Puerta, E., Romão, M. A., Gomes, C. M., Merino‐Serrais, P., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02521-8 · Cited by 37
1,8-Cineole Ameliorates Advanced Glycation End Products-Induced Alzheimer’s Disease-like Pathology In Vitro and In Vivo
An, F.-M., Bai, Y., Xuan, X., Bian, M., Zhang, G., & Wei, C. (2022) · Molecules · doi:10.3390/molecules27123913 · Cited by 36
Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells
Wang, X., Yu, S., Wang, C., Wang, Y., Liu, H., Cui, Y., & Zhang, L.-D. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9823-5 · Cited by 35
Effect of natural flavonoids, stilbenes and caffeic acid oligomers on protein glycation
Sasaki, K., CHIBA, S., & Yoshizaki, F. (2014) · Biomedical Reports · doi:10.3892/br.2014.304 · Cited by 35
Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
Kamal, M. A., Priyamvada, S., Anbazhagan, A. N., Jabir, N. R., Tabrez, S. S. M., & Greig, N. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660137 · Cited by 37
Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Arab, L., Sadeghi, R., Walker, D. G., Lue, L.-F., & Sabbagh, M. N. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376334 · Cited by 35
Uncovering Neurodegenerative Protein Modifications via Proteomic Profiling
Gallart‐Palau, X., Serra, A., & Sze, S. K. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.06.002 · Cited by 29
Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion
Liu, H., Xing, A., Wang, X., Liu, G., & Li, L. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.027 · Cited by 31
AGE-RAGE in Multiple Sclerosis Brain
Sternberg, Z., Ostrow, P. T., Vaughan, M. M., Chichelli, T., & Munschauer, F. E. (2010) · Immunological Investigations · doi:10.3109/08820139.2010.532267 · Cited by 31
Anti-RAGE and A Immunoglobulin Levels Are Related to Dementia Level and Cognitive Performance
Wilson, J. S., Mruthinti, S., Buccafusco, J. J., Schade, R., Mitchell, M. B., Harrell, D., Gulati, N. K., & Miller, L. S. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/gln002 · Cited by 31
Diabetes and Cognitive Dysfunction
Sims‐Robinson, C., Kim, B., & Feldman, E. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00013-6 · Cited by 30
Interaction Effect between the Receptor for Advanced Glycation End Products (RAGE) and High-Mobility Group Box-1 (HMGB-1) for the Migration of a Squamous Cell Carcinoma Cell Line
Choi, J., Lee, M. K., Oh, K. H., Kim, Y. S., Choi, H. Y., Baek, S., Jung, K., Woo, J., Lee, S. H., & Kwon, S. Y. (2011) · Tumori Journal · doi:10.1177/030089161109700211 · Cited by 27
Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
Harris, R. A., & Amor, S. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794488656 · Cited by 27
Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia
Takeda, M., Ohnuma, T., Takeuchi, M., Katsuta, N., Maeshima, H., Takebayashi, Y., Higa, M., Nakamura, T., Nishimon, S., Sannohe, T., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.002 · Cited by 25
Self-citation
The Amyloid Cascade Hypothesis 2.0 for Alzheimer’s Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
Lue, L., Andrade, C., Sabbagh, M. N., & Walker, D. G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/918680 · Cited by 24
A standardized randomized 6-month aerobic exercise-training down-regulated pro-inflammatory genes, but up-regulated anti-inflammatory, neuron survival and axon growth-related genes
Iyalomhe, O., Chen, Y., Allard, J. S., Ntekim, O. E., Johnson, S. M., Bond, V., Goerlitz, D. S., Li, J., & Obisesan, T. O. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.005 · Cited by 25
Alzheimer’s Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1007 · Cited by 23
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
Modulation of Astrocytic Activation by Arundic Acid (ONO-2506) Mitigates Detrimental Effects of the Apolipoprotein E4 Isoform after Permanent Focal Ischemia in Apolipoprotein E Knock-in Mice
Mori, T., Town, T., Tan, J. R., Tateishi, N., & Asano, T. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600063 · Cited by 22
Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease
Tsoy, A., Umbayev, B. A., Kassenova, A., Kaupbayeva, B., & Askarova, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010964 · Cited by 24
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
Pathogenic Role of RAGE in Tau Transmission and Memory Deficits
Kim, Y., Park, H., Kim, Y., Kim, S., Lee, J., Yang, H., Kim, S. J., Li, C. M., Lee, H., Na, D.-H., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.10.015 · Cited by 23
Analysis of Serum of Patients With Alzheimer’s Disease for the Level of Advanced Glycation End Products
Leszek, J., Małyszczak, K., Bartyś, A., Staniszewska, M. M., & Gamian, A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506291075 · Cited by 21
Innate and adaptive immunity in neurodegenerative disease
Huang, Y., Zhang, G., Li, S., Feng, J., & Zhang, Z. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05533-4 · Cited by 22
Suppression of BACE1 and amyloidogenic/RAGE axis by sitagliptin ameliorates PTZ kindling-induced cognitive deficits in rats
Safar, M. M., Shahin, N. N., Mohamed, A. F., & Abdelkader, N. F. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109144 · Cited by 19
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
Drake, L. R., Brooks, A. F., Stauff, J., Sherman, P. S., Arteaga, J., Koeppe, R. A., Reed, A. D., Montavon, T. J., Skaddan, M. B., & Scott, P. J. H. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.07.009 · Cited by 18
Radiolabeling of [ 11 C]FPS-ZM1, a Receptor for Advanced Glycation End products-targeting Positron Emission Tomography radiotracer, Using a [ 11 C]CO 2 -to-[ 11 C]CO Chemical Conversion
Luzi, F., Savickas, V., Taddei, C., Hader, S., Singh, N., Gee, A. D., & Bongarzone, S. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0329 · Cited by 17
Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus
Deren, K. E., Forsyth, J., Abdullah, O., Hsu, E. W., Klinge, P. M., Silverberg, G. D., Johanson, C. E., & McAllister, J. P. (2009) · Cerebrospinal Fluid Research · doi:10.1186/1743-8454-6-4 · Cited by 19
Age-Dependent Expression of Advanced Glycation End Product Receptor Genes in the Human Heart
Caßelmann, C. A., Reimann, A., Friedrich, I., Schubert, A., Silber, R., & Simm, A. (2004) · Gerontology · doi:10.1159/000076770 · Cited by 19
LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
Pluta, R. M., Kocki, J., Bogucki, J., Bogucka‐Kocka, A., & Czuczwar, S. J. (2023) · Cells · doi:10.3390/cells12232763 · Cited by 20
Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention
Ahmad, S., & Farhan, M. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_8 · Cited by 18
Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathology
Rodríguez, M. H., Flores‐Clemente, C., Macías-Pérez, M. E., Rodríguez-Fonseca, R. A., Nicolás‐Vázquez, M. I., Martínez, J. O., Miranda, R., Rosas, M., & Jiménez, E. M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00405-9 · Cited by 17
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration
Pehar, M., & Kinscherf, N. A. (2022) · Current Drug Targets · doi:10.2174/1389450123666220610171005 · Cited by 17
Up-Regulation in Receptor for Advanced Glycation End-Products in Inflammatory Circumstances in Bovine Coccygeal Intervertebral Disc Specimens In Vitro
Yoshida, T., Park, J. S., Yokosuka, K., Jimbo, K., Yamada, K., Sato, K., Takeuchi, M., Yamagishi, S., & Nagata, K. (2009) · Spine · doi:10.1097/brs.0b013e3181a98390 · Cited by 17
Self-citation
Long‐Term Intake of Uncaria rhynchophylla Reduces S100B and RAGE Protein Levels in Kainic Acid‐Induced Epileptic Seizures Rats
Tang, N.-Y., Lin, Y., Ho, T., Cheng, C.-Y., Chen, C.-H., & Hsieh, C. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/9732854 · Cited by 18
Relationship Between the Induction of RAGE Cell-Surface Antigen and the Expression of Amyloid Binding Sites
Mruthinti, S., Hill, W., Swamy-Mruthinti, S., & Buccafusco, J. J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:223 · Cited by 17
Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases
Natale, G., Pompili, E., Biagioni, F., Paparelli, S., Lenzi, P., & Fornai, F. (2013) · European Journal of Histochemistry · doi:10.4081/ejh.2013.e5 · Cited by 16
Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights
Sanaie, S., Nikanfar, S., Yousefi, Z., Azizi-Zeinalhajlou, A., Sadigh‐Eteghad, S., Araj‐Khodaei, M., Ayati, M. H., & Andalib, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01059-5 · Cited by 15
RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats
Yang, F., Wang, H., Chen, H., Ran, D., Tang, Q., Weng, P., Sun, Y., & Jiang, W. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.020 · Cited by 14
The Amyloid Cascade Hypothesis 2.0: On the Possibility of Once-in-a-Lifetime-Only Treatment for Prevention of Alzheimer’s Disease and for Its Potential Cure at Symptomatic Stages
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220031 · Cited by 15
Ceria nanocluster-based therapy for Alzheimer’s disease through the modulation of activated microglia and attenuation of amyloid-β deposition
Liu, H.-J., Wang, M., Wang, Y., Shi, S., Hu, X., Zhang, D.-B., Fan, D., Mintzer, J., & Xu, P. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100158 · Cited by 13
Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target
Sarkar, S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03595-6 · Cited by 13
Fluorescence in probing the biochemical and conformational changes in non-enzymatically glycated proteins
Ameera, K., Mukunda, D. C., Basha, S., Rodrigues, J., Biswas, S., Mazumder, N., Prabhu, V. K., Prabhu, M. M., & Mahato, K. K. (2025) · Applied Spectroscopy Reviews · doi:10.1080/05704928.2025.2477237 · Cited by 13
Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer’s Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (iAβ) by Its Targeted Degradation via Augmentation of Intra-iAβ-Cleaving Activities of BACE1 and/or BACE2
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417586 · Cited by 13
Protective Effects of Troxerutin on β-Amyloid (1-42)-Induced Impairments of Spatial Learning and Memory in Rats
Babri, S., Amani, M., Mohaddes, G., Alihemmati, A., & Ebrahimi, H. (2012) · Neurophysiology · doi:10.1007/s11062-012-9309-6 · Cited by 12
Alzheimer’s Disease Prevention and Treatment: Case for Optimism
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1008 · Cited by 11
A strategic tool to improve the study of molecular determinants of Alzheimer’s disease: The role of glyceraldehyde
Piccirillo, S., Preziuso, A., Cerqueni, G., Serfilippi, T., Terenzi, V., Vinciguerra, A., Amoroso, S., Lariccia, V., & Magi, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115869 · Cited by 10
Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer’s Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions
Volloch, V., & Rits‐Volloch, S. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230037 · Cited by 11
Harnessing neurogenesis in the adult brain—A role in type 2 diabetes mellitus and Alzheimer's disease
Lazarov, O., Minshall, R. D., & Bonini, M. G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.020 · Cited by 9
News from Mars: Two-Tier Paradox, Intracellular PCR, Chimeric Junction Shift, Dark Matter mRNA and Other Remarkable Features of Mammalian RNA-Dependent mRNA Amplification. Implications for Alzheimer’s Disease, RNA-Based Vaccines and mRNA Therapeutics
Volloch, V., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1009 · Cited by 10
Growth Factors, AGEing, and the Diabetes Link in Alzheimer's Disease
Loy, C. T., & Twigg, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0997 · Cited by 10
On the Inadequacy of the Current Transgenic Animal Models of Alzheimer’s Disease: The Path Forward
Volloch, V., & Rits‐Volloch, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052981 · Cited by 9
Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer’s Disease Patients
Haddad, M., Perrotte, M., Khedher, M. R. B., Madec, E., Page, A. Y. L., Fülöp, T., & Ramassamy, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210441 · Cited by 10
Pathogenesis of Alzheimer disease
Pavlović, D. M., Pavlovic, A. M., & Zugic, S. (2007) · Vojnosanitetski pregled · doi:10.2298/vsp0711765p · Cited by 8
Dementia and diabetes mellitus
Pavlović, D. M., & Pavlovic, A. M. (2008) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0804170p · Cited by 8
Erratum to: Protective Effects of Troxerutin on β-Amyloid (1-42)-Induced Impairments of Spatial Learning and Memory in Rats
Babri, S., Amani, M., Mohaddes, G., Alihemmati, A., & Ebrahimi, H. (2012) · Neurophysiology · doi:10.1007/s11062-012-9328-3 · Cited by 8
A promising structural magnetic resonance imaging assessment in patients with preclinical cognitive decline and diabetes mellitus
Dong, Y., Wang, Q., Yao, H., Xiao, Y., Wei, J., Xie, P., Hu, J., Chen, W., Tang, Y., Zhou, H., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28359 · Cited by 6
Expression in plants of two new antigens with implications in Alzheimer’s disease immunotherapy
Romero‐Maldonado, A., Monreal‐Escalante, E., & Rosales‐Mendoza, S. (2016) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-016-0990-9 · Cited by 7

Authors: Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., & Makita, Z.
Affiliations: Sapporo Medical University (JP)
Hokuriku University (JP)
Kurume University (JP)
Corresponding author: Sasaki, Nobuyuki
Venue: Brain Research
Publisher: Elsevier BV
Published: 2001-01
Volume: 888
Issue: 2
Pages: 256-262
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/s0006-8993(00)03075-4
OpenAlex: W2091657472
Cited by: 253
References: 29
Citations by year: 2026: 2 · 2025: 8 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 15 · 2020: 13 · 2019: 10 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 13 · 2013: 20 · 2012: 8
FWCI: 6.28
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
Funders: Ministry of Education, Culture, Sports, Science and Technology
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: receptor for advanced glycation end products, advanced glycation end products, Alzheimer's disease, amyloid-beta, astrocytes, hippocampal neurons, diabetes mellitus, lysosomal degradation, colocalization, neuronal dysfunction
MeSH terms: Receptor for Advanced Glycation End Products, Aged, Alzheimer Disease, Animals, Antibody Specificity, Astrocytes, Cattle, Diabetes Mellitus, Female, Humans, Immunohistochemistry, Male, Middle Aged, Neurons, Receptors, Immunologic, Blotting, Western, Amyloid beta-Peptides, Glycation End Products, Advanced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks